High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology
Abstract Introduction Antimullerian hormone (AMH) strongly correlates with ovarian reserve and response to controlled ovarian stimulation. Emerging data suggests that serum AMH level may also predict ART outcomes. However, AMH is characteristically elevated in PCOS women and it is unknown whether it...
Saved in:
Main Authors: | Reshef Tal (Author), Charles M. Seifer (Author), Moisey Khanimov (Author), David B. Seifer (Author), Oded Tal (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
by: Munawar Hussain, et al.
Published: (2013) -
AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles
by: Howard J. Li, et al.
Published: (2023) -
Successful Same-Cycle Blastocyst Transfer following Laparoscopic Ovarian Detorsion: A Report of Two Cases and Literature Review
by: Mohamad Irani, et al.
Published: (2014) -
Prediction of Ovarian Response by Antimullerian Hormone in Women with Polycystic Ovarian Syndrome: A Randomized Prospective Study
by: Elsaid N
Published: (2016) -
AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles
by: Christopher Arkfeld, et al.
Published: (2023)